Authors


Payton L. Noble

Latest:

Poison Prevention Packaging Act Continues to Save Children’s Lives

The notable federal public health and pharmacy practice law celebrates its 50th anniversary in 2020.


Richard A. Mularski, MD, MSHS, MCR

Latest:

Web Exclusive: Pharmacist Glycemic Control Team Associated With Improved Perioperative Glycemic and Utilization Outcomes

Implementation of a pharmacist-led glycemic control team was associated with improved glycemic control and utilization outcomes in a population of noncritically ill surgical patients.


Harry Lattanzio, PRS Pharmacy Services

Latest:

2010 Industry Advocate of the Year: Harry Lattanzio

Harry Lattanzio has started 3 businesses that meet the needs of the pharmacy industry-it is no wonder that he was chosen.


Mark Thomas, PharmD, MSPBA Candidate

Latest:

Multiple Sclerosis: The Central Nervous System Destroyer

There is no cure for multiple sclerosis, but there are more than a dozen treatment options that aid in reducing the severity of the disease.


Shahnawaz Khan, RPh

Latest:

Treatment of Diabetes and Angioedema Risk

Pharmacists must be aware of potentially serious adverse reactions in patients receiving angiotensin- converting enzyme therapy, particularly with the concurrent use of dipeptidly peptidase IV inhibitors.


Ami Buikema, MPH

Latest:

Impact of Co-Payment Discounts on Antidepressant Medication Adherence and Costs

A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.


Anne Compton-Brown, JD

Latest:

State Regulation of Telepharmacy

State regulation of telepharmacy varies depending on the market-driven needs within each particular state.


Roger Chou, MD

Latest:

Impact of Medicaid Preferred Drug List on Long-Acting Opioid Users

An opioid preferred drug list was not associated with an increase in emergency department visits or hospitalizations in a Medicaid population.


Franklin Hendrick, BS

Latest:

Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies

Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.


Philip D. Hansten, PharmD

Latest:

Estrogens and Lamotrigine: New Developments

Practitioners have known for almost 2 decades that oral contraceptives consistently and substantially reduce the serum concentrations of lamotrigine and may reduce seizure control.


Mark K. Barnes

Latest:

Specialty Pharmaceuticals: Manufacturers Must Consider a New Supply Chain

Future strategies to manage specialty drugs are geared toward improving overall health care management of patients rather than relying on supply chain cost reduction strategies. The management of specialty drugs requires strategies that focus on outcomes and value.



Robert J. Dudzinski, PhD

Latest:

3 Crucial Considerations for Pharmacists in the Age of Consumerism

As consumers take on more financial responsibility for their health care, their need grows for more engagement with their pharmacists.



Gérard Forzy, PhD

Latest:

Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis Treatment

The authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.


Vice President of Development, Dunn Meadow Pharmacy

Latest:

A Look Back and at What Lies Ahead for Specialty Pharmacy in 2019

There is no doubt that 2018 was a year of transformation across the health care spectrum, and specialty pharmacy was no exception.


Patrick P. Gleason, PharmD, BCPS, FCCP

Latest:

A Linezolid Prior Authorization Program: Clinical and Economic Outcomes

This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.


Martha Quintana, BSN, RN,

Latest:

Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing Barriers

This paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.


Jennifer G. Allen

Latest:

How Many Americans with High Cholesterol Could be Eligible for PCSK9 Inhibitors?

Specialty drug costs for 13 to 23 million patients in the United States would be $185 to 342 billion.


Con Lane

Latest:

Sponsored Content: Expand Your Pharmacy Footprint

With national brand recognition and expert support, pharmacy franchise owners reach more patients.


Janet Shin, PharmD

Latest:

Impact of Drug Therapy Duration in Patients With Hepatitis C

Adherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.


Ruby Mhajan, RPh

Latest:

Specialty Drugs: Year in Review 2017 Part II

The second part of a comprehensive review of the specialty pharmaceuticals approved by the FDA in 2017.






Allen Amedume, PharmD Candidate 2021

Latest:

The Impact of COVID-19 on Medical Science Liaisons

Most notably, COVID-19 has transformed the landscape for medical science liaisons (MSLs) by forcing them to rapidly adapt to the present circumstances.


George Citroner

Latest:

Millennials Not Receiving HIV Tests

Half of millennial-aged men and women said they have never been tested for HIV outside of blood donation.


Joe Thomas, PharmD, MSPBA Candidate

Latest:

Specialty Pharmacy: Ignoring What It Is and Making It What We Want

Current definitions attempting to summarize specialty pharmacy fall short.